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1. Introduction 
The Hurler, Scheie and Hurler-Scheie syndromes 
are all characterized as the deficiency diseases of 
a!-L-iduronidase (EC 3.2.1.76) [ 1,2]. For understand- 
ing their different clinical manifestations [l-3], how- 
ever, more detailed characte~~ation of this enzyme 
will be required. During the course of pu~fication of 
a-L-iduronidase from the commercial bovine liver 
/3-glucuronidase preparation, we found a hitherto 
undescribed enzyme species active toward 4-methyl- 
umbelliferyl cu-L-iduronide. 
This paper describes the presence of two distinct 
species of a-L-iduronidase in the bovine liver prepara- 
tion and raises the possibility that &$rcuronidase 
may play a role for the catabolism of a-L-iduronic 
acid-containing glycosaminoglycans. 
2. Materials and methods 
2.1. chemicals 
4.Methylumbe~ife~l cw-L-iduronide was prepared 
as in [4]. Phenyl ff-L-iduronide was purchased from 
Zeria Shinyaku Kogyo (Tokyo). An authentic speci- 
men of 4,6-Q-isopropylidene$-L-idofuranurono-6,3- 
lactone was commercially obtained from Nakarai 
Chem. (Kyoto). 4-Methylumbelliferyl @-D-glucuronide 
was from Koch-Light Labs. D-Saccharic acid-l ,4- 
lactone (saccharolactone} was from Sigma Chem. 
Bovine liver &&rcuronidase was a preparation of 
Worthington Biochem. (CL 35A991). 
2.2. Emyme QSSQY 
4-Methylumbe~iferyl ~-L-iduronjdase activity was 
measured in 0.2 ml total vol. of 0.1 M sodium acetate 
buffer (pH 4.0) containing 0.9% NaCl, 50 nmol 
substrate and 50 ~1 enzyme solution. After incuba- 
tion at 37°C for 30 min, the reaction was stopped by 
adding 3 ml 0.2 M sodium carbonate buffer (pH IO) 
and fluorescence was measured as in 141. Phenyl 
a-L-iduronidase activity was determined according 
to the manufacturer’s instruction using 125 pmol 
substrate and 0.2 ml solution to be assayed (see also 
[S]). &Clucuronidase activity was assayed as in [4] 
using 4-methylumbe~iferyl ~-D-~ucuronide except 
that incubations were at 37°C. 
2.3. Fractionation of the bovine liver /I-glucuronidase 
preparation 
The commercial preparation with specific glucuro- 
nidase activity of 1.25 pmol .h-l .mg protein-’ (102 mg) 
was dissolved in 5 ml 0.1 M sodium acetate buffer, 
(pH 5.0) and fractionated by gel-filtration through an 
Ultrogel AcA22 column (2.5 X 138 cm) equilibrated 
with the same buffer. The fraction containing fl-glucu- 
ronidase activity was further purified by a DEAE- 
cellulose column (1.5 X 9 cm) in 0.02 M Tris-HCl 
buffer (pH 7.3). With a linear gradient elution from 
O-O.3 M NaCl(200 ml each) a single peak fraction 
containing /3-glucuronidase activity was eluted at 
0.12 M NaCl. This fraction was gel-filtered through 
an Ultrogel AcA22 column (1.4 X 46 cm) and the 
active fraction to the ~-glucuronide was concentrated 
with a Diafilter and dialyzed against 0.1 M sodium 
acetate buffer (pH 4.5). The protein was determined 
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as in [4]. Apparent molecular weights were determined Fraction PI contained 4-methylumbelliferyl iduro- 
by Sephadex G-l 50 column as in [6],usingEscherichiu nidase activity corresponding to 1.8% of /3-glucuro- 
coli fi-galactosidase, bovine serum albumin, ovalbumin nidase activity but was devoid of phenyl a-l-iduro- 
and horse cytochrOme c as standards. nidase activity. 
3. Results and discussion 
Preliminary experiments showed that the commer- 
cial fi-glucuronidase preparation contained several 
glycosidases including /3-galactosidase, /3-glucosidase 
and N-acetyl-fl-glucosaminidase. Also fluorescence 
was observed when 4-methylumbelliferyl iduronide 
was incubated with this preparation. A chromatographic 
pattern of this preparation through Ultrogel is seen in 
fig.1. Two peak fractions (fractions I, II) were active 
toward 4-methylumbelliferyl iduronide but only 
fraction II had phenyl iduronidase activity. Fraction I 
was further purified as mentioned above and a final 
preparation with specific /3-glucuronidase activity of 
2.8 pmol .h-’ .mg protein-’ was designated as frac- 
tion PI. During these chromatographic separations 
4-methylumbelliferyl iduronidase activity was always 
co-chromatographed with &glucuronidase activity. 
Although the purity of 4-methylumbelliferyl 
cr-L-iduronide was not rigorously established [4], 
several ines of evidence supported the idea that frac- 
tion PI did hydrolyze this substrate. We showed [4] 
by gas-chromatographic examination that a maximum 
contamination of the P-glucuronide was O.l%, if at all. 
The present gas-chromatographic study of commer- 
cially obtained 4,6-O-isopropylidene-iduronolactone 
confirmed the assignments of peaks to those due to 
iduronic acid [4]. A molar extinction coefficient of 
the cyclohexylammonium salt of the same substrate 
prepared by a different method [7] was reported to be 
14 900 which agreed with our value of 14 400 [4]. 
More convincing evidence came from the identifica- 
tion of the product as seen in fig.2. Fraction PI 
(110 pg protein) and 4-methylumbelliferyl iduronide 
(1420 nmol) were incubated at 25°C for 24 h. Under 
this condition, 4.2% of the substrate was hydrolyzed. 
Control incubation (without enzyme solution) gave a 
value corresponding to 0.4% of hydrolysis. The reac- 
tion mixture was separated by DEAE-cellulose 
chromatography as in [4 1. The reducing compound 
eluted first was identified to be iduronic acid (fig.2). 
Paper chromatography [8] of this product after 
lactonization confirmed this finding (data not shown). 
The unhydrolyzed substrate was recovered in another 
fraction. The hydrolyses of the original substrate and 
the recovered one by fraction PI with total /3-glucuro- 
nidase activity of 46.5 nmol .h-’ were both linear up 
to at least 3 h at 37°C and the initial rates were 
comparable (0.84 and 0.87 nmol/h, respectively). 
FRACTION NUMBER 
Fig.1. Gel-filtration of the commercial @-glucuronidase prepa- 
ration through Ultrogel AcA 22. The column (2.5 x 138 cm) 
was equilibrated with 0.02 M Tris-HCl buffer (pH 7.3) and 
elution was performed with the same buffer. Each fraction 
contained 11 ml and was monitored by A,,, (0). Enzymatic 
activities for 4-methylumbelliferyl p-D-glucuronide (B), 
4-methylumbelliferyl or-L-iduronide (0) and phenyl or-l-iduro- 
nide (A) were determined utilizing 50 1.r1 of each fraction. 
The pH-dependent activity curves for combina- 
tions of enzymes with substrates are shown in fig.3. 
a-L-Iduronidase of fraction PI was different from that 
of fraction II in that the former showed no activity at 
pH < 3.0 (fig.3). The hydrolysis of 4-methylumbel- 
liferyl iduronide by fraction PI was inhibited by 
saccharolactone which is an inhibitor for fi-glucuro- 
nidase [9]. Apparent inhibition was 88% and 94% in 
the presence of 10 PM and 50 PM inhibitor, respec- 
tively. In contrast, no appreciable inhibition by 
saccharolactone was observed in the system of frac- 
tion II and 4-methylumbelliferyl cu-L-iduronide under 
similar conditions. 
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Fig.2. Paper electrophoretic examination of the reaction 
product obtained after incubation of 4-methylumbelliferyl 
a-L-iduronide with fraction PI, followed by separation with 
DEAE-cellulose (41. Electrophoresis was performed with 
pyridine-acetic acid-water-formic acid (pH 3.0) [ 161 for 
2 h at 20 V/cm and spots were visualized with an alkaline 
silver nitrate reagent [4]. (1) A mixture of glucuronic acid 
and iduronic acid; (2, 6) iduronic acid; (3) the reaction prod- 
uct; (4) the reaction product plus glucuronic acid; (5) glucu- 
ronic acid. 
Apparent molecular weights of enzyme (s) of frac- 
tion PI and fraction II were estimated to be 290 000 
and 78 000, respectively. Those for bovine liver 
fl-glucuronidase [lo], human urine and kidney a-L- 
iduronidases [6,1 l] have been reported to be 290 000, 
87 000 and 60 000 + 6500, respectively. 
These data suggest hat at least two distinct 
enzyme species hydrolyzing 4-methylumbelliferyl 
iduronide are present in the bovine liver preparation. 
The possibility that fraction PI contained an aggregated 
form of fraction II cannot be excluded but seems less 
likely in view of their different behavior toward pH 
and the inhibitor. 
3.0 4.0 5.0 6.0 
PH 
Fig.3. Enzymatic activity curves depending on pH for com- 
binations of fractions with the substrates. Activities were 
determined in 0.1 M sodium formate buffer (open symbols) 
and in 0.1 M sodium acetate buffer (closed symbols). (A) 
Fraction PI versus 4-methylumbelliferyl P-D-glucuronide. 
(o, 0) Fraction PI versus 4-methylumbelliferyl a-L-iduronide. 
(0, n ) Fraction II versus 4-methylumbelliferyl a-L-iduronide. 
These observations led the authors to the suggestion 
that /3-glucuronidase may share o-L-iduronidase as an 
intrinsic property. If so, the residual activity in the 
Hurler and Scheie syndromes [4,12,13] as detected 
with this substrate might be in part due to P-glucuro- 
nidase activity. 
Since phenyl cu-L-iduronide was not a substrate for 
the /3-glucuronidase fraction, the conformation of the 
iduronic acid residue may differ from that in the 
4-methylumbelliferyl glycoside. Although the rela- 
tionship among steric structures of this residue in 
these substrates and native glycosaminoglycans is not 
clear at present, this study raises the possibility that 
/3-glucuronidase may play a role in the degradation of 
certain iduronic acid-containing mucopolysaccharides. 
This suggestion could provide an answer to the 
unsettled question as to why /I-glucuronidase deficient 
patients accumulate dermatan sulfate and heparan 
sulfate [1,14,15]. 
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